Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The highly vesicant nature of the alkylating anticancer agent mechlorethamine (
HN2
, or nitrogen mustard) requires careful i.v. technique during its administration. Skin toxicity due to
HN2
extravasation is severe and typically prolonged over several months. Mouse skin toxicity studies were carried out to find a local antidote to decrease the severity of tissue damage by this agent. Intradermal (i.d.)
HN2
(0.005-0.5 mg) caused dose-dependent skin ulcers in the mouse. Isotonic sodium thiosulfate Na2S2O3 (0.167 M) or hypertonic (0.34 M) Na2S2O3 (0.05 ml) given immediately after
HN2
significantly reduced the mean
HN2
ulceration area and the total time of ulceration. Ineffective local
HN2
antidotes included
hyaluronidase
, hydrocortisone, and sodium chloride, all given i.d. Topical applications of DMSO, cold, and heat were also ineffective. Sodium thiosulfate is believed to chemically neutralize reactive mechlorethamine-alkylating species and thus decrease skin toxicity. Thiosulfate dosing studies showed that a molar excess of at least 200:1 (Na2S2O3:
HN2
) was required for significant antidotal activity. If thiosulfate treatment was delayed 4-24 h after
HN2
, no antidotal effects were obtained. We conclude that sodium thiosulfate can decrease the severity of local tissue damage caused by
HN2
. It should be considered the antidote of choice in the setting of clinical
HN2
extravasations.
...
PMID:Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. 316 43